Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study
The feasibility of redo-TAVI with an S3 in an ACn2 depends on the implant depth of the S3 and the geometry of the surrounding aorta. A low S3 implant may reduce the risk of coronary flow compromise and inaccessibility.
Authors
- Arif Khokhar (ORCID: https://orcid.org/0000-0002-4455-2865)
- Miho Fukui (ORCID: https://orcid.org/0000-0002-7235-5551)
- Gintautas Bieliauskas (ORCID: https://orcid.org/0000-0002-4509-6654)
- Ole De Backer (ORCID: https://orcid.org/0000-0002-9674-0278)
- Vinayak Bapat (ORCID: https://orcid.org/0000-0002-2579-6434)
- Mohamed Abdel‐Wahab (ORCID: https://orcid.org/0000-0002-9596-558X)
- João L. Cavalcante (ORCID: https://orcid.org/0000-0002-3632-2074)
- Yusuke Kobari (ORCID: https://orcid.org/0000-0002-6144-9747)
- Kentaro Hayashida (ORCID: https://orcid.org/0000-0002-1750-1982)
- Gilbert H.L. Tang (ORCID: https://orcid.org/0000-0001-7219-990X)
- Andreas Fuchs (ORCID: https://orcid.org/0000-0003-0236-0811)
- Klaus Fuglsang Kofoed (ORCID: https://orcid.org/0000-0001-9742-1554)
- Darren Mylotte (ORCID: https://orcid.org/0000-0001-7824-2577)
- Ahmed Abdelhafez (ORCID: https://orcid.org/0000-0002-1019-0536)
- Dariusz Dudek
Institutions
- Jagiellonian University (PL)
- Mount Sinai Health System (US)
- Keio University (JP)
- University Hospital Galway (IE)
- Rigshospitalet (DK)
- Leipzig Heart Institute (DE)
- Minneapolis Heart Institute Foundation (US)
Publication Details
- Journal
- EuroIntervention
- Published
- 2024-11-01
- DOI
- https://doi.org/10.4244/eij-d-24-00367
- Citations
- 4
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Boston Scientific Corporation